Company Filing History:
Years Active: 2017-2020
Title: A Deep Dive into the Innovations of Inventor Na Meng
Introduction
Na Meng, an esteemed inventor based in Shanghai, CN, has made significant contributions to the field of pharmacology with a total of six patents to her name. Her innovative work primarily focuses on the development of orexin receptor antagonists. These advancements hold potential implications for treating various neurological and psychiatric disorders, showcasing the impact of her research on public health.
Latest Patents
Na Meng's latest patents highlight her pioneering research in the area of orexin receptor antagonists. One of her key inventions is titled "Fused heteroaryl derivatives as orexin receptor antagonists." This invention emphasizes the potential application of fused heteroaryl derivative compounds in treating or preventing diseases associated with orexin receptors. Additionally, a key aspect of this patent is the formulation of pharmaceutical compositions that leverage these compounds for therapeutic benefits.
Another notable patent is "Piperidine oxadiazole and thiadiazole orexin receptor antagonists." This innovation introduces piperidine oxadiazole and thiadiazole compounds that act as antagonists for orexin receptors, with similar applications in addressing neurological and psychiatric disorders. This patent also emphasizes the importance of the compositions that include these compounds for treatment and prevention purposes.
Career Highlights
Na Meng currently works at Merck Sharp & Dohme Corporation, a leading global healthcare company. Throughout her career, she has demonstrated a commitment to advancing the understanding and treatment of neurological disorders through her innovative research. The significance of her patents is underscored by the potential they hold in addressing critical health issues faced by society.
Collaborations
In her journey as an inventor, Na Meng collaborates with esteemed colleagues such as Nigel J Liverton and Scott D Kuduk. These partnerships enhance her research endeavors and contribute to the broad spectrum of pharmaceutical innovations aimed at improving patient outcomes in neurology and psychiatry.
Conclusion
Na Meng's contributions to the field of pharmacology through her six patents are a testament to her innovative spirit and dedication to medical science. Her research on orexin receptor antagonists holds promising potential for addressing various neurological and psychiatric disorders, illuminating a path toward improved therapeutic interventions. As she continues her work at Merck Sharp & Dohme Corporation, the medical community eagerly anticipates the impact of her future innovations.